Activated monocytes and markers of inflammation in newly diagnosed multiple sclerosis

Subgroups of monocytes predict cardiovascular events in patients with coronary heart disease.The PHAMOS trial (Prospective Halle Monocytes Study)

(2019) Florian Höpfner et al.   Hellenic Journal of Cardiology

Nonclassical monocytes: are they the next therapeutic targets in multiple sclerosis?

(2018) Bahareh Ajami et al.   IMMUNOLOGY AND CELL BIOLOGY

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

(2018) Alan J Thompson et al.   LANCET NEUROLOGY

Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis

(2017) Mikkel Carstensen Gjelstrup et al.   IMMUNOLOGY AND CELL BIOLOGY

The fate and lifespan of human monocyte subsets in steady state and systemic inflammation

(2017) Amit A. Patel et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years

(2017) Sergio E. Baranzini et al.   TRENDS IN GENETICS

MRI in the assessment and monitoring of multiple sclerosis: an update on best practice

(2017) Ulrike W. Kaunzner et al.   Therapeutic Advances in Neurological Disorders

Phenotype, function, and differentiation potential of human monocyte subsets

(2017) Lisa B. Boyette et al.   PLoS One

Human endogenous retroviruses in neurologic disease

(2016) Tove Christensen   APMIS

Pivotal Role for CD16+Monocytes in Immune Surveillance of the Central Nervous System

(2016) Anne Waschbisch et al.   JOURNAL OF IMMUNOLOGY

Biomarkers in multiple sclerosis

(2015) William J. Housley et al.   CLINICAL IMMUNOLOGY

Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study

(2015) Yoko Yokoyama et al.   CYTOTHERAPY

Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses

(2015) Lazaros Belbasis et al.   LANCET NEUROLOGY

Transcriptional activity of endogenous retroviruses in multiple sclerosis: a sign of deficient chromatin-mediated silencing

(2015) Christian Muchardt   Epigenomics

Blood Monocytes and Their Subsets: Established Features and Open Questions

(2015) Loems Ziegler-Heitbrock   Frontiers in Immunology

Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel

(2015) Morten Stilund et al.   PLoS One

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial

(2014) Christopher Ritchlin et al.   ANNALS OF THE RHEUMATIC DISEASES

The plasticity of inflammatory monocyte responses to the inflamed central nervous system

(2014) Thomas Myles Ashhurst et al.   CELLULAR IMMUNOLOGY

Expansion and preferential activation of the CD14+ CD16+ monocyte subset during multiple sclerosis

(2014) Delgertsetseg Chuluundorj et al.   IMMUNOLOGY AND CELL BIOLOGY

Differential roles of microglia and monocytes in the inflamed central nervous system

(2014) Ryo Yamasaki et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Interleukin-7 expression and its effect on natural killer cells in patients with multiple sclerosis

(2014) Ning Su et al.   JOURNAL OF NEUROIMMUNOLOGY

Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies

(2014) Dean M. Wingerchuk et al.   MAYO CLINIC PROCEEDINGS

Monocyte Expression and Soluble Levels of the Haemoglobin Receptor (CD163/sCD163) and the Mannose Receptor (MR/sMR) in Septic and Critically Ill Non-Septic ICU Patients

(2014) Anders G. Kjærgaard et al.   PLoS One

Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event

(2014) Darin T. Okuda et al.   PLoS One

Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: Heterogeneous involvement of the “a disintegrin and metalloproteases” 10 and 17

(2013) Guranda Chitadze et al.   INTERNATIONAL JOURNAL OF CANCER

Structural Basis for Inflammation-driven Shedding of CD163 Ectodomain and Tumor Necrosis Factor-α in Macrophages

(2013) Anders Etzerodt et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status

(2013) Daphne YS Vogel et al.   Journal of Neuroinflammation

Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis

(2013) Charlotte Teunissen et al.   Multiple Sclerosis Journal

The three human monocyte subsets: implications for health and disease

(2012) Kok Loon Wong et al.   IMMUNOLOGIC RESEARCH

Effects of interferon-beta therapy on elements in the antiviral immune response towards the human herpesviruses EBV, HSV, and VZV, and to the human endogenous retroviruses HERV-H and HERV-W in multiple sclerosis

(2012) Thor Petersen et al.   JOURNAL OF NEUROIMMUNOLOGY

Expression of HERV-Fc1, a Human Endogenous Retrovirus, Is Increased in Patients with Active Multiple Sclerosis

(2012) M. J. Laska et al.   JOURNAL OF VIROLOGY

Translational biomarker discovery in clinical metabolomics: an introductory tutorial

(2012) Jianguo Xia et al.   Metabolomics

Disease Biomarkers in Multiple Sclerosis

(2012) Violaine K. Harris et al.   Molecular Diagnosis & Therapy

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets

(2011) K. L. Wong et al.   BLOOD

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

(2011) Ludwig Kappos et al.   LANCET

Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool

(2011) Bahareh Ajami et al.   NATURE NEUROSCIENCE

Nomenclature of monocytes and dendritic cells in blood

(2010) L. Ziegler-Heitbrock et al.   BLOOD

HERVs in Neuropathogenesis

(2010) Tove Christensen   Journal of Neuroimmune Pharmacology

Increased Monocyte Turnover from Bone Marrow Correlates with Severity of SIV Encephalitis and CD163 Levels in Plasma

(2010) Tricia H. Burdo et al.   PLoS Pathogens

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

(2009) C. E. Teunissen et al.   NEUROLOGY

B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity

(2009) Tomasz Brudek et al.   Retrovirology

Multiple sclerosis

(2008) Alastair Compston et al.   LANCET

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

(2008) Benjamin M Segal et al.   LANCET NEUROLOGY

Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome

(2008) D. T. Okuda et al.   NEUROLOGY

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE